Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #123951 on Biotech Values
genisi
07/27/11 6:59 AM
#124005 RE: DewDiligence #123951
According to NVS’ 2Q11 CC, 55% of US Gilenya patients were previously taking no drug for MS